WELCOME TO THE COGNITE ALZHEIMER’S CLINICAL TRIAL!

Are you or someone you know experiencing memory loss? Are you or someone you know having trouble retaining information? This may be an indication of early stage Alzheimer’s disease, which is a type of dementia that causes problems with an individual’s memory, thinking, and behavior.

The Cognite Alzheimer’s Clinical Trial is enrolling men and women between the ages of 55 and 79 who have signs of early stage Alzheimer’s disease. The clinical trial is evaluating whether the effect of an investigational combined treatment slows down, arrests, or reverses early stage Alzheimer’s disease.

Imagine making an impact! Your participation in the Cognite Alzheimer’s Clinical Trial could help doctors find new ways to diagnose and treat early stage Alzheimer’s disease for you and future generations.

I MAY HAVE EARLY STAGE ALZHEIMER’S DISEASE. WHAT DOES THAT MEAN?

Alzheimer’s disease is a form of dementia that causes problems with an individual’s memory, thinking, and behavior. It is not a part of normal aging and researchers are studying new ways to treat and slow down the disease.

I AM READY TO LEARN MORE ABOUT THE COGNITE CLINICAL TRIAL, AND I WANT TO SEE IF I PREQUALIFY.